Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Plos One|September 30, 2016
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal CancerJérôme Solassol, Julie Vendrell, Bruno Märkl, et al.
Gynecologic Oncology|May 13, 2022
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 studyRoisin E O'Cearbhaill, Jose-Alejandro Pérez-Fidalgo, Bradley J Monk, et al.
Bone|August 10, 2014
Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study)Agustí Barnadas, Luis Manso, Concepción de la Piedra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancersLaura Visa, Jordi Badia-Ramentol, Maria Concepción Fernández, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 2023
Pre-existing tumor host immunity characterization in resected non-small cell lung cancerPedro Rocha, Maite Rodrigo, Laura Moliner, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2019
Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung CancerSolène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER TrialJoan Albanell, José Manuel Pérez-García, Miguel Gil-Gil, et al.
Annals of Hematology|August 30, 2022
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia VeraAna Triguero, Alexandra Pedraza, Manuel Pérez-Encinas, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
Pageof 22